Exemples d'utilisation de Basic patent en Anglais et leurs traductions en Français
{-}
-
Colloquial
-
Official
Number of the basic patent.
The basic patent and the SPC.
Le brevet de base et les CCP.Any product protected by a basic patent* in force;
Pour tout produit protégé par un brevet de base* en vigueur;O the basic patent is revoked or limited.
O si le brevet de base est annulé ou limité.(a) the product is protected by a basic patent in force;
Le produit* est protégé par un brevet de base* en vigueur;
Instructions for basic patent and licensed private pilot.
Instruction pour brevet de base et The indications for determining the basic patent.
Des indications permettant The basic patent has lapsed before its duration term;
Si le brevet de base s'est éteint avant l'expiration The product is protected by a basic patent in force;
Le produit doit être protégé par un brevet de base en vigueur.The basic patent has lapsed before its lawful term expires;
Si le brevet de base s'est éteint avant l'expiration A SPC confers the same rights as the basic patent.
Le CCP confère les mêmes droits que ceux qui sont conférés par le brevet de base.The Office uses the basic patent number with an addition("CNNNNNN".
L'office utilise le numéro du brevet de base précédé d'un caractère("CNNNNNN".Rejection of the scope of protection of the basic patent test.
Sur le rejet du test du champ (iii) the number of the basic patent and the title of the invention;
Iii le numéro du brevet de base, ainsi que le titre Filing date, application number anddate of grant of the basic patent.
Date Claim Nos 1,32 and 33 of the basic patent are worded as follows.
Les revendications 1,32 et 33 du brevet de base sont libellées comme suit.Mr President, the SPC has the same legal effect as the basic patent.
Les effets juridiques Understand the basic patent and regulatory framework governing commercialization of drugs, devices, and services.
Comprendre les brevets de base et le cadre réglementaire régissant la commercialisation des médicaments, des dispositifs et des services.Pat. No. 3,855,031 may be considered as the basic patent in this field.
Le Boehreinger's basic patent is entitled‘Benzimidazol derivatives, medicaments containing them and process for their preparation.
Le brevet de base Boehringer est intitulé«Dérivés du benzimidazole, médicaments les contenant et procédé pour leur préparation.Genentech contends that that formulation falls within the scope of protection of the basic patent.
Genentech soutient que ladite formulation relève du champ In the case where a product is protected by one basic patent, the period of sui generis protection shall take effect at the end of the lawful term of that patent. .
Lorsqu'un produit est protégé par un seul brevet de base, la période The terms"other therapeutic ingredients" are however not defined or explained in the basic patent.
Les termes“autres ingrédients thérapeutiques” ne sont toutefois ni définis ni expliqués dans le brevet de base.In the case where all the patents that may serve as a basic patent are held by the same person, selected by the person requesting the period of sui generis protection; and.
Si tous les The protection conferred by the certificate cannot exceed the scope of the protection conferred by the basic patent.
La protection conférée par le certificat ne peut pas excéder l'étendue Any medicinal product protected by a valid basic patent and for which the first authorisation to place it on the market as a medicinal product was obtained after 1 January 2000 may be granted a certificate in Romania.
Tout médicament qui est protégé par un brevet de base en vigueur et pour lequel, en tant que médicament, This means that results from research after the filing or priority date of the basic patent are excluded.
Exclusion In the case where the patents that may serve as a basic patent are not held by the same person and this gives rise to conflicting requests for the sui generis protection, selected by agreement between the patent holders.
Si les Subject: The Court affirmed that Regulation(EC)No 469/2009 concerning the supplementary protection certificate for medicinal products must be interpreted as precluding the competent industrial property office of a Member State from granting a supplementary protection certificate relating to active ingredients which are not specified in the wording of the claims of the basic patent relied on in support of the application for such a certificate.
Objet: La Cour a affirmé que le règlement(CE)n° 469/2009, concernant le certificat complémentaire In the case where a product is protected by more than one patent that may serve as a basic patent, a Party may provide for only a single period of sui generis protection, which takes effect at the end of the lawful term of the basic patent. .
Lorsqu'un produit est protégé par plus d'un 
